Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2016

View Archived Issues

FAK inhibition shows potential as a target for combination with immunotherapy

miR-1246 and miR-1290 as novel therapeutic targets and biomarkers of disease progression

University of Vermont and State Agricultural College patents autophagy inhibitors

Auspex Pharmaceuticals discloses cytochrome P450 CYP11B1 inhibitors

Novira Therapeutics describes antiviral agents

Madrigal Pharmaceuticals, Synta Pharmaceuticals complete merger

EMA committee recommends approval of Onivyde in E.U.

EMA's CHMP grants positive opinion to Cabometyx in RCC

XBiotech reports progress for Xilonix in U.S. and E.U.

EMA committee supports approval of Eisai's Kisplyx

Euroscreen opens IND for three phase II studies of ESN-364

IDO activity shows promise as a biomarker for tuberculosis

FDA grants QIDP and fast track designations to MCB-3837 for C. difficile infection

Roche updates pipeline progress of second quarter 2016

Increased sCD74 serum levels correlate with severity of lung injury

miR-877-3p as a potential new fibrosis marker for predicting prognosis

Functional rs353292 polymorphism in the flanking region of miR-143/145 as risk factor for CRC

InflaRx raises funds in series C financing

VIB and Oxford Nanopore Technologies collaborate on DNA sequencing technology

Almirall and Patagonia Pharmaceuticals enter licensing agreement

EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada

Grant supports work at The Scripps Research Institute on stem cells for Parkinson's disease

Sunovion reports results of SUN-101/eFlow phase III study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...